predictive biomarkers of neoadjuvant chemosensitivity in muscle invasive bladder cancer | oncotarget
Published 1 year ago • 41 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
19:21
immunotherapy for muscle invasive bladder cancer
-
1:06:18
biomarker-guided neoadjuvant therapy for bladder cancer
-
0:57
biomarkers for muscle-invasive bladder cancer in the ambassador trial
-
0:47
role of predictive biomarkers in patients with mibc
-
2:48
using biomarkers to identify bladder cancer patients for neoadjuvant therapy
-
6:49
the role of biomarkers in bladder cancer
-
8:00
neoadjuvant and adjuvant therapy in muscle-invasive bladder cancer
-
1:24
next steps in neoadjuvant chemotherapy for muscle-invasive bladder cancer
-
0:58
oncotarget: novel urine protein biomarkers in bladder cancer
-
0:40
neoadjuvant sacituzumab govitecan for muscle-invasive bladder cancer
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer
-
4:37
prof. witjes - non-muscle invasive bladder cancer (nmibc) surveillance and the role of biomarkers
-
0:59
concurrent chemo-radiation in muscle invasive bladder cancer
-
11:35
update on first biomarker-directed trial of non-muscle-invasive bladder cancer
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
1:25
overcoming challenges in localized bladder cancer management via biomarkers
-
45:14
definitive radiation-based therapy for muscle invasive bladder cancer
-
8:21
introduction: neoadjuvant chemotherapy in bladder cancer
-
1:42:08
trimodality therapy for management of muscle invasive bladder cancer